Author

Wanrui Wang

University of Notre DameORCID 0000-0001-9757-7364Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

BRANDON MARTIN· 1 shared Emily Cronberger· 1 shared Emily Richardson· 1 shared Gena M. Dominique· 1 shared Ijeoma Asilebo· 1 shared JEFFREY JOHNSON· 1 shared Jing Yang· 1 shared Mary Sharon StackiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

BRANDON MARTIN

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer

Jing Yang, Tyvette S. Hilliard, Yueying Liu, Emily Richardson, SOPHIA SANTOSO, Viktoriia Khomenko, Molly B. Conroy, BRANDON MARTIN, Emily Cronberger, Gena M. Dominique, Zhikun Wang, JEFFREY JOHNSON, Wanrui Wang, Ijeoma Asilebo, Mary Sharon Stack

This study shows that inhibiting SREBP1 with Nelfinavir improves chemotherapy response in obesity-associated ovarian cancer by reprogramming the immune microenvironment.

bioRxiv · Sep 16, 2026 · PreprintCancer Biology